“Vocal Supporter” of Vaccines Nominated to Be CDC Director
On Apr. 17, 2026, the Trump administration nominated retired Coast Guard rear admiral and former deputy surgeon general Erica Schwartz, MD, JD, MPH to be the next director of the U.S. Centers for Disease Control and Prevention (CDC). If confirmed by the U.S. Senate, Dr. Schwartz would succeed Jay Bhattacharya, MD, PhD who has been […]
Sen. Johnson Questions RFK, Jr. in Trump Budget Request Hearing
Because the pandemic is over, so many people just want to put it behind us… let’s not examine all the things that went wrong. One group of people who do not want to move on, who insist on a reckoning, are those who are injured by the COVID mRNA injection. On VAERS today, worldwide, we […]
National Cancer Institute to Study Ivermectin as Potential Cancer Treatment
The National Cancer Institute (NCI) plans to conduct a study on the use of ivermectin to treat cancer, according to a top official. Ivermectin is an FDA-approved anti-parasitic medication commonly used to treat various infections caused by internal and external parasites, such as parasitic worms and head lice, though the drug rose in popularity—and scrutiny—during […]
American Medical Association Launches Its Own Vaccine Review Process
The American Medical Association (AMA), a medical trade advocacy association, is partnering with a vaccine research group to launch what it describes as an independent, “evidence-based review process” for respiratory vaccines for the next flu season—a role traditionally carried out by the U.S. Centers for Disease Control and Prevention (CDC).1 2 According to a prepared […]
AAP Issues Its Own Recommended Childhood Vaccine Schedule
The American Academy of Pediatrics (AAP) has released its own recommended childhood vaccine guidance, breaking with updated recommendations issued earlier this month by the U.S. Centers for Disease Control and Prevention (CDC).1 On Jan. 6, 2026, the CDC formally updated the U.S. childhood vaccination schedule, introducing changes as to how vaccines are categorized and recommended. […]
Novavax Signs Licensing Agreement With Pfizer for Vaccine Adjuvant Technology
Novavax, Inc. and Pfizer, Inc. have signed a licensing arrangement allowing Pfizer access to Novavax’s Matrix-M adjuvant technology to boost immune response to vaccines. The agreement will allow for use in vaccines targeting up to two infectious diseases.1 Novavax’s Matrix-M technology is an aluminum-free adjuvant designed to enhance the immune response in protein-based vaccines such […]